Profilo
Petr Kocis has worked as a Vice President-Preclinical Development at Alzheon, Inc. since 2015.
Posizioni attive di Petr Kocis
| Società | Posizione | Inizio |
|---|---|---|
| ALZHEON, INC. | Corporate Officer/Principal | 01/01/2015 |
Esperienze
Posizioni ricoperte
Relazioni
13
Relazioni di 1° grado
1
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Alzheon, Inc.
 Alzheon, Inc. BiotechnologyHealth Technology Alzheon, Inc. engages in the provision of medical development. It specializes in treatment for brain health, memory, and aging. It offers ALZ-801, an oral small molecule inhibitor of amyloid formation and neurotoxicity with potential to be a therapy for a genetically defined population of patients with or at high risk for Alzheimer's disease and other neurodegenerative disorders. The company was founded by Martin Tolar in June 2013 and is headquartered in Framingham, MA. | Health Technology |
- Borsa valori
- Insiders
- Petr Kocis
